COVID-19 infection linked to increased cases of ME/CFS

New findings from the National Institutes of Health’s (NIH) Researching COVID to Enhance Recovery (RECOVER) Initiative suggest that infection with SARS-CoV-2, the virus that causes COVID-19, may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.

Lovo-Cel ‘Life-Changing, Transformative’ in Sickle Cell Disease

SAN DIEGO — A one-time treatment with lovotibeglogene autotemcel (Lyfgenia, lovo-cel) achieved near complete resolution of severe pain crises in patients with sickle cell disease

December 11, 2023

Editas to cut 65% of workforce, officially stops work on ex vivo sickle cell therapy

Editas Medicine will eliminate about 180 roles after failing to find a commercial partner for its experimental sickle cell therapy, and will halt development of

December 13, 2024

Opinion | Want Electronic Reimbursement? That Will Cost You a 5% Fee.

Soloman is a rheumatologist. If you’re like most Americans, you prefer to be paid electronically instead of with old-fashioned paper checks. But imagine if your

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.